Editors: Editorial Board

The views & opinions expressed are those of the contributing authors and editors and do not necessarily represent the views of the ACC. More

  • Hot Topic

    Recently completed trials have provided evidence supporting extending the duration of therapy with anticoagulation for patients with VTE; but, these studies have also raised further questions regarding the optimal treatment strategy for patients with VTE.

    More
  • Article of the Month

    An expert review of the ROCKET AF trial by Dr. Yuichi Shimada.

    More
  • Video

    IMPACT: Anticoagulation Guided by Remote Rhythm Monitoring in Patients With ICD and Resynchronization Devices

    More
  • Video

    BRAVE 4: Prasugrel and Bivalirudin vs. Clopidogrel and Heparin in STEMI Patients

    More
  • Community

    Visit this community to learn more about and discuss topics related to the entire class of novel oral anticoagulants.

    More
  • Resource

    As a member of The Evolution of Anticoagulation Management – Atrial Fibrillation (TEAM-A) partnership, the ACC is pleased to share access to valuable resources.

    More

advertisement

SITE SPONSORED BY

advertisement